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ABSTRACT 
Tuberculosis (TB), caused by Mycobacterium tuberculosis complex (MTBC), is 
an infectious disease with more than 10.4 million cases and 1.7 million deaths reported 
worldwide in 2016. The classical methods for detection and differentiation 
of mycobacteria are: acid-fast microscopy (Ziehl-Neelsen staining), culture, and 
biochemical methods. However, the microbial phenotypic characterization is time-
consuming and laborious. Thus, fast, easy, and sensitive nucleic acid amplification tests 
(NAATs) have been developed based on specific DNA markers, which are commercially 
available for TB diagnosis. Despite these developments, the disease remains 
uncontrollable. The identification and differentiation among MTBC members with the use 
of NAATs remains challenging due, among other factors, to the high degree of homology 
within the members and mutations, which hinders the identification of specific target 
sequences in the genome with potential impact in the diagnosis and treatment 
outcomes. In silico methods provide predictive identification of many new target 
genes/fragments/regions that can specifically be used to identify species/strains, which 
have not been fully explored. This review focused on DNA markers useful for MTBC 
detection, species identification and antibiotic resistance determination. The use of DNA 
targets with new technological approaches will help to develop NAATs applicable to all 
levels of the health system, mainly in low resource areas, which urgently need customized 
methods to their specific conditions. 
 
